0000885590-15-000019.txt : 20150304 0000885590-15-000019.hdr.sgml : 20150304 20150304172430 ACCESSION NUMBER: 0000885590-15-000019 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150302 FILED AS OF DATE: 20150304 DATE AS OF CHANGE: 20150304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chai-Onn Robert Roswell CENTRAL INDEX KEY: 0001502213 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 15674497 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST CITY: LAVAL STATE: A8 ZIP: H7L 4A8 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2015-03-02 0 0000885590 Valeant Pharmaceuticals International, Inc. VRX 0001502213 Chai-Onn Robert Roswell 2150 ST. ELZEAR BLVD. WEST LAVAL A8 H7L 4A8 QUEBEC, CANADA 0 1 0 0 EVP, CLO, General Counsel Common Stock, no par value 2015-03-02 4 M 0 90939 25.42 A 112296 D Common Stock, no par value 2015-03-02 4 S 0 90939 200.0142 D 21379 D Common Stock, no par value 2015-03-03 4 M 0 21808 6.1 A 43187 D Non-Qualified Stock Options (right to purchase) 25.42 2015-03-02 4 M 0 90939 0 D 2014-10-08 2015-11-11 Common shares, no par value 90939 90938 D Non-Qualified Stock Options (right to purchase) 6.1 2015-03-03 4 M 0 21808 0 D 2009-11-01 2015-11-01 Common shares, no par value 21808 21807 D This number represents options exercised and sold pursuant to a 10b5-1 trading plan covering these options, which were to expire on November 11, 2015. This number represents the weighted average sale price for all sales of common stock acquired upon exercise of options and sold, in each case pursuant to a 10b5-1 trading plan. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price. This number represents options exercised and held pursuant to a 10b5-1 trading plan covering these options, which were to expire on November 1, 2015. The options vested one-fourth per year over four years starting with the first vest date falling on the first anniversary of the vesting commencement date, the second vest date falling on the second anniversary of the vesting commencement date, the third vest date falling on the third anniversary of the vesting commencement date, and the fourth vest date falling on the fourth anniversary of the vesting commencement date. by: Nicholas Zanoni for Robert Chai-Onn 2015-03-04